Item 1.01. Entry into a Material Definitive Agreement.
On December 6, 2019 (the "Closing Date"), Centene Corporation ("Centene" or the
"Company"), issued $1,000,000,000 in aggregate principal amount of 4.75% Senior
Notes due 2025 (the "Additional 2025 Notes"), $2,500,000,000 in aggregate
principal amount of 4.25% Senior Notes due 2027 (the "2027 Notes") and
$3,500,000,000 in aggregate principal amount of 4.625% Senior Notes due 2029
(the "2029 Notes," and together with the Additional 2025 Notes and the 2027
Notes, the "Notes"). The Notes were sold to persons reasonably believed to be
qualified institutional buyers in reliance on Rule 144A and to non-U.S. persons
outside the United States in reliance on Regulation S. The Notes have not been
registered under the Securities Act of 1933, as amended (the "Securities Act"),
or any state securities laws and, unless so registered, may not be offered or
sold in the United States except pursuant to an exemption from, or in a
transaction not subject to, the registration requirements of the Securities Act
and applicable state securities laws.
The Company intends to use the net proceeds of the 2027 Notes and the 2029 Notes
and a portion of the net proceeds of the Additional 2025 Notes to finance the
cash consideration payable in connection with the Company's previously announced
acquisition (the "Merger") of WellCare Health Plans, Inc. ("WellCare") and to
pay related fees and expenses. The Company expects to use the remainder of the
net proceeds of the Additional 2025 Notes for general corporate purposes,
including the repayment of revolver borrowings.
The Additional 2025 Notes will be issued under an Indenture, dated as of
December 6, 2019 (the "Additional 2025 Notes Indenture"), by and between the
Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the
"Trustee"). The Additional 2025 Notes will mature on January 15, 2025. Interest
on the Additional 2025 Notes is payable on January 15 and July 15 of each year,
beginning on January 15, 2020. The 2027 Notes will be issued under an Indenture,
dated as of December 6, 2019 (the "2027 Notes Indenture"), by and between the
Company and the Trustee. The 2027 Notes will mature on December 15, 2027.
Interest on the 2027 Notes is payable on June 15 and December 15 of each year,
beginning on June 15, 2020. The 2029 Notes will be issued under an Indenture,
dated as of December 6, 2019 (the "2029 Notes Indenture," and together with the
Additional 2025 Notes Indenture and the 2027 Notes Indenture, the "Indentures"),
by and between the Company and the Trustee. The 2029 Notes will mature on
December 15, 2029. Interest on the 2029 Notes is payable on June 15 and December
15 of each year, beginning on June 15, 2020.
At any time prior to January 15, 2020, the Company may redeem the Additional
2025 Notes, in whole or in part, at a price equal to 100% of the principal
amount of the Additional 2025 Notes redeemed, plus any accrued and unpaid
interest thereon and a "make-whole" premium. The Company may redeem the
Additional 2025 Notes, in whole or in part, at any time on or after January 15,
2020 at redemption prices of 103.563%, 102.375% and 101.188% of the principal
amount thereof if the redemption occurs during the 12-month periods beginning on
January 15 of the years 2020, 2021 and 2022, respectively, and at a redemption
price of 100% of the principal amount thereof on and after January 15, 2023, in
each case plus accrued and unpaid interest, if any, to the redemption date.
At any time prior to December 15, 2022, the Company may redeem the 2027 Notes,
in whole or in part, at a price equal to 100% of the principal amount of the
2027 Notes redeemed, plus any accrued and unpaid interest thereon and a
"make-whole" premium. The Company may redeem the 2027 Notes, in whole or in
part, at any time on or after December 15, 2022 at redemption prices of
102.125%, 101.417% and 100.708% of the principal amount thereof if the
redemption occurs during the 12-month periods beginning on December 15 of the
years 2022, 2023 and 2024, respectively, and at a redemption price of 100% of
the principal amount thereof on and after December 15, 2025, in each case plus
accrued and unpaid interest, if any, to the redemption date. In addition, at any
time prior to December 15, 2022, the Company may redeem up to 40% of the
aggregate principal amount of the 2027 Notes at a redemption price of 104.25% of
the principal amount thereof, plus accrued and unpaid interest, if any, to, but
excluding, the redemption date, with an amount equal to or less than the net
cash proceeds of one or more qualifying equity offerings.
At any time prior to December 15, 2024, the Company may redeem the 2029 Notes,
in whole or in part, at a price equal to 100% of the principal amount of the
2029 Notes redeemed, plus any accrued and unpaid interest thereon and a
"make-whole" premium. The Company may redeem the 2029 Notes, in whole or in
part, at any time on or after December 15, 2024 at redemption prices of
102.313%, 101.542% and 100.771% of the principal amount thereof if the
redemption occurs during the 12-month periods beginning on December 15 of the
years 2024, 2025 and 2026, respectively, and at a redemption price of 100% of
the principal amount thereof on and after December 15, 2027, in each case plus
accrued and unpaid interest, if any, to the redemption date. In addition, at any
time prior to December 15, 2024, the Company may redeem up to 40% of the
aggregate principal amount of the 2029 Notes at a redemption price of 104.625%
of the principal amount thereof, plus accrued and unpaid interest, if any, to,
but excluding, the redemption date, with an amount equal to or less than the net
cash proceeds of one or more qualifying equity offerings.
--------------------------------------------------------------------------------
If the Company experiences specific kinds of changes of control, it will be
required to offer to purchase each series of Notes at a purchase price equal to
101% of the principal amount, plus accrued and unpaid interest.
If the Merger is not consummated on or before September 26, 2020, or if, prior
to such date, the Agreement and Plan of Merger relating to the Merger (the
"Merger Agreement") is terminated or the Company notifies the Trustee or
otherwise announces that the Company has determined that the Merger Agreement
has been or will be terminated or that the Merger will not otherwise be pursued,
the Company will be required to redeem the 2027 Notes and the 2029 Notes at a
special mandatory redemption price equal to 100% of their principal amount, plus
accrued and unpaid interest, if any, to, but excluding, the date of redemption.
The Notes will be senior unsecured obligations of the Company and will be equal
in right of payment with each other and with all of the Company's existing and
future senior indebtedness and will be senior in right of payment to any of the
Company's existing and future subordinated debt. The Notes will not be
guaranteed by any of the Company's subsidiaries.
The Indentures provide for customary events of default, including failure to
make required payments; failure to comply with certain agreements or covenants;
failure to pay, or acceleration of, certain other material indebtedness; certain
events of bankruptcy and insolvency; and failure to pay certain judgments. An
event of default under the applicable Indenture will allow either the Trustee or
the holders of at least 25% in principal amount of the then outstanding Notes of
the applicable series to accelerate, or in certain cases, will automatically
cause the acceleration of, the amounts due under the applicable series of Notes.
The foregoing descriptions of the Notes and the Indentures are qualified in
their entirety by reference to the full text of the Indentures (including the
forms of notes attached thereto). A copy of the Additional 2025 Notes Indenture
is attached as Exhibit 4.1 hereto, a copy of the 2027 Notes Indenture is
attached as Exhibit 4.2 hereto and a copy of the 2029 Notes Indenture is
attached as Exhibit 4.3 hereto and each is incorporated herein by reference.
The Company and Barclays Capital Inc., J.P. Morgan Securities LLC, SunTrust
Robinson Humphrey, Inc., Wells Fargo Securities, LLC and BofA Securities, Inc.
(collectively the "Representatives of Initial Purchasers") entered into a
registration rights agreement (the "Additional 2025 Notes Registration Rights
Agreement") pursuant to which the Company agreed to use its reasonable best
efforts to file a registration statement to permit the exchange of the
Additional 2025 Notes for registered notes having terms substantially identical
to the $1,200,000,000 aggregate principal amount of 4.75% senior notes due 2025
that were issued under the indenture dated November 9, 2016 or, in the
alternative, the registered resale of the Additional 2025 Notes, in each case
under certain circumstances. Additionally, the Company and the Representatives
of Initial Purchasers entered into a registration rights agreement for the 2027
Notes (the "2027 Notes Registration Rights Agreement") and a registration rights
agreement for the 2029 Notes (the "2029 Notes Registration Rights Agreement"),
pursuant to which the Company agreed to use its reasonable best efforts to file
a registration statement to permit the exchange of the 2027 Notes and the 2029
Notes for registered notes having terms substantially identical thereto (except
that the registered notes will not contain terms with respect to transfer
restrictions or special mandatory redemption) or, in the alternative, the
registered resale of the 2027 Notes and the 2029 Notes, in each case under
certain circumstances. If the Company fails to satisfy its obligations under the
. . .
Item 2.03. Creation of a Direct Financial Obligation or an Obligation Under and
Off-Balance Sheet Arrangement of a Registrant.
The information in Item 1.01 above is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Description
Number
4.1 Indenture, dated as of December 6, 2019, by and between Centene
Corporation, as issuer, and The Bank of New York Mellon Trust Company,
N.A., as trustee, relating to the Company's 4.75% Senior Notes due 2025
(including the Form of Global Note attached thereto).
4.2 Indenture, dated as of December 6, 2019, by and between Centene
Corporation, as issuer, and The Bank of New York Mellon Trust Company,
N.A., as trustee, relating to the Company's 4.25% Senior Notes due 2027
(including the Form of Global Note attached thereto).
4.3 Indenture, dated as of December 6, 2019, by and between Centene
Corporation, as issuer, and The Bank of New York Mellon Trust Company,
N.A., as trustee, relating to the Company's 4.625% Senior Notes due 2029
(including the Form of Global Note attached thereto).
4.4 Registration Rights Agreement, dated December 6, 2019, by and among
Centene Corporation, and Barclays Capital Inc., J.P. Morgan Securities
LLC, SunTrust Robinson Humphrey, Inc., Wells Fargo Securities, LLC, and
BofA Securities, Inc., as representatives of the initial purchasers,
relating to the Company's 4.75% Senior Notes due 2025.
4.5 Registration Rights Agreement, dated December 6, 2019, by and among
Centene Corporation, and Barclays Capital Inc., J.P. Morgan Securities
LLC, SunTrust Robinson Humphrey, Inc., Wells Fargo Securities, LLC, and
BofA Securities, Inc., as representatives of the initial purchasers,
relating to the Company's 4.25% Senior Notes due 2027.
4.6 Registration Rights Agreement, dated December 6, 2019, by and among
Centene Corporation, and Barclays Capital Inc., J.P. Morgan Securities
LLC, SunTrust Robinson Humphrey, Inc., Wells Fargo Securities, LLC, and
BofA Securities, Inc., as representatives of the initial purchasers,
relating to the Company's 4.625% Senior Notes due 2029.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses